Moderna CEO says it’s ‘reasonable’ to think pandemic may be in its final stages
[ad_1]
Moderna’sStephane Bancel CEO stated that it is “reasonable” to believe we are approaching the end stages of pandemic.
When asked his opinion on whether the Covid-19 pandemic is now in its final stages, he said “I think it’s a reasonable situation.”
“There’s an 80% chance that as omicron evolves or SarsCov-2 virus evolves, we are going to see less and less virulent viruses,” he said Wednesday.
The other “20%” scenario is where we will see another mutation that’s more potent than the micron.
“I think we got lucky as a world that omicron was not very virulent, but still are we see thousands of people dying every day around the planet because of omicron,” he said.
According to the World Health OrganizationGlobally, worldwide there have been 15.47 million cases and 73.162 deaths over the 7-day period.
We want to grow in Asia because of its importance. This virus will not go away. It is like the flu, and it is something that we have to deal with.
Stephane Bancel
Moderna, CEO
In January Moderna announcedIt began a clinical study to determine the safety and effectiveness of the booster shot targeting the specific omicron variant.
According to the company, the initial participant of the trial received the booster shot omicron specific. About 600 participants aged 18-plus are expected to sign up. The two groups will then be separated.
Asia expansion plans
Moderna, however, announced separate plans. expand its presence in Asia.
CNBC was told by he that the reason they wanted to expand in Asia was because of its importance.
“The fact that this virus is not going away, as we’ve been saying since almost the beginning — this virus is going to stay with humans forever, like flu and we’d have to live with it.”
Bancel stated that he is excited by Asia’s economic growth and said the company plans to open subsidiaries in Malaysia and Singapore.
Moderna, a U.S.-based biotech company stated in a statement that the expansion is happening as it “continues scaling up the manufacturing of its COVID-19 vaccination and future mRNA therapies and therapeutics.”
Moderna’s messenger-RNA vaccine is not currently available in Hong Kong. surge in Covid cases. Bancel stated that the company was currently working with authorities to obtain authorization.
[ad_2]